Specifically, vaccination with p53-transduced DCs combined with ATRA in lung cancer patients resulted in a significant depletion of MDSCs in more than twofold, that was accompanied by more p53-specific responses compared to vaccination alone (128). Here, TP53 is linked to lung carcinoma.